1. Home
  2. TRVI vs API Comparison

TRVI vs API Comparison

Compare TRVI & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • API
  • Stock Information
  • Founded
  • TRVI 2011
  • API 2013
  • Country
  • TRVI United States
  • API United States
  • Employees
  • TRVI N/A
  • API N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • API Computer Software: Prepackaged Software
  • Sector
  • TRVI Health Care
  • API Technology
  • Exchange
  • TRVI Nasdaq
  • API Nasdaq
  • Market Cap
  • TRVI 211.4M
  • API 223.6M
  • IPO Year
  • TRVI 2019
  • API 2020
  • Fundamental
  • Price
  • TRVI $2.75
  • API $4.39
  • Analyst Decision
  • TRVI Strong Buy
  • API
  • Analyst Count
  • TRVI 8
  • API 0
  • Target Price
  • TRVI $9.13
  • API N/A
  • AVG Volume (30 Days)
  • TRVI 659.5K
  • API 1.5M
  • Earning Date
  • TRVI 11-06-2024
  • API 11-25-2024
  • Dividend Yield
  • TRVI N/A
  • API N/A
  • EPS Growth
  • TRVI N/A
  • API N/A
  • EPS
  • TRVI N/A
  • API N/A
  • Revenue
  • TRVI N/A
  • API $138,287,000.00
  • Revenue This Year
  • TRVI N/A
  • API N/A
  • Revenue Next Year
  • TRVI N/A
  • API $8.09
  • P/E Ratio
  • TRVI N/A
  • API N/A
  • Revenue Growth
  • TRVI N/A
  • API N/A
  • 52 Week Low
  • TRVI $0.97
  • API $1.65
  • 52 Week High
  • TRVI $4.00
  • API $6.43
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 37.52
  • API 61.20
  • Support Level
  • TRVI $2.80
  • API $4.00
  • Resistance Level
  • TRVI $3.22
  • API $5.47
  • Average True Range (ATR)
  • TRVI 0.20
  • API 0.53
  • MACD
  • TRVI -0.03
  • API 0.11
  • Stochastic Oscillator
  • TRVI 14.68
  • API 60.73

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: